Sultana O, Bandaru M, Islam M, Reddy P
Ageing Res Rev. 2024; 100:102414.
PMID: 39002647
PMC: 11384519.
DOI: 10.1016/j.arr.2024.102414.
Stevens D, Workman C, Kuwabara H, Butters M, Savonenko A, Nassery N
Brain Commun. 2022; 4(1):fcac016.
PMID: 35233522
PMC: 8882008.
DOI: 10.1093/braincomms/fcac016.
Huang Y, Cho H, Bandara N, Sun L, Tran D, Rogers B
Chem Sci. 2021; 11(30):7789-7799.
PMID: 34094152
PMC: 8163150.
DOI: 10.1039/d0sc02641g.
Jasiecki J, Targonska M, Wasag B
Int J Mol Sci. 2021; 22(4).
PMID: 33670778
PMC: 7922581.
DOI: 10.3390/ijms22042033.
Jorge L, Martins R, Canario N, Xavier C, Abrunhosa A, Santana I
J Alzheimers Dis. 2021; 80(1):113-132.
PMID: 33523050
PMC: 8075404.
DOI: 10.3233/JAD-200840.
Mixed-location cerebral microbleeds as a biomarker of neurodegeneration in a memory clinic population.
Gyanwali B, Shaik M, Tan C, Vrooman H, Venketasubramanian N, Chen C
Aging (Albany NY). 2019; 11(22):10581-10596.
PMID: 31767809
PMC: 6914397.
DOI: 10.18632/aging.102478.
Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
Auvity S, Tonietto M, Caille F, Bodini B, Bottlaender M, Tournier N
Eur J Nucl Med Mol Imaging. 2019; 47(2):490-501.
PMID: 31686177
DOI: 10.1007/s00259-019-04516-z.
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.
Chandra A, Valkimadi P, Pagano G, Cousins O, Dervenoulas G, Politis M
Hum Brain Mapp. 2019; 40(18):5424-5442.
PMID: 31520513
PMC: 6864887.
DOI: 10.1002/hbm.24782.
Biological Assessment of a F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer's Disease as a Potential Astrocytosis Marker.
Kreimerman I, Reyes A, Paolino A, Pardo T, Porcal W, Ibarra M
Front Neurosci. 2019; 13:734.
PMID: 31379487
PMC: 6646682.
DOI: 10.3389/fnins.2019.00734.
Correlation between β-amyloid deposits revealed by BF-227-PET imaging and brain atrophy detected by voxel-based morphometry-MR imaging: a pilot study.
Maeno N
Nucl Med Commun. 2019; 40(9):905-912.
PMID: 31246935
PMC: 6708599.
DOI: 10.1097/MNM.0000000000001042.
Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline.
Martikainen I, Kemppainen N, Johansson J, Teuho J, Helin S, Liu Y
AJNR Am J Neuroradiol. 2018; 40(1):80-85.
PMID: 30545837
PMC: 7048601.
DOI: 10.3174/ajnr.A5891.
Imaging Biomarkers in Alzheimer's Disease: A Practical Guide for Clinicians.
Sheikh-Bahaei N, Sajjadi S, Manavaki R, Gillard J
J Alzheimers Dis Rep. 2018; 1(1):71-88.
PMID: 30480230
PMC: 6159632.
DOI: 10.3233/ADR-170013.
Imaging the evolution and pathophysiology of Alzheimer disease.
Jagust W
Nat Rev Neurosci. 2018; 19(11):687-700.
PMID: 30266970
PMC: 7032048.
DOI: 10.1038/s41583-018-0067-3.
In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.
Ogawa K, Shiba K
Contrast Media Mol Imaging. 2018; 2018:4535476.
PMID: 30008624
PMC: 6020543.
DOI: 10.1155/2018/4535476.
Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology.
Gordon B, McCullough A, Mishra S, Blazey T, Su Y, Christensen J
Alzheimers Dement (Amst). 2018; 10:245-252.
PMID: 29780869
PMC: 5956934.
DOI: 10.1016/j.dadm.2018.02.003.
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
Villemagne V, Dore V, Burnham S, Masters C, Rowe C
Nat Rev Neurol. 2018; 14(4):225-236.
PMID: 29449700
DOI: 10.1038/nrneurol.2018.9.
Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.
Sheikh-Bahaei N, Sajjadi S, Pierce A
Curr Treat Options Neurol. 2017; 19(12):46.
PMID: 29134465
DOI: 10.1007/s11940-017-0484-z.
Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in Cu PET Imaging for Alzheimer's Disease.
Sharma A, Schultz J, Prior J, Rath N, Mirica L
Inorg Chem. 2017; 56(22):13801-13814.
PMID: 29112419
PMC: 5698879.
DOI: 10.1021/acs.inorgchem.7b01883.
A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults.
Taylor M, Sullivan D, Swerdlow R, Vidoni E, Morris J, Mahnken J
Am J Clin Nutr. 2017; 106(6):1463-1470.
PMID: 29070566
PMC: 5698843.
DOI: 10.3945/ajcn.117.162263.
Evaluation of Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer's Disease.
Bandara N, Sharma A, Krieger S, Schultz J, Han B, Rogers B
J Am Chem Soc. 2017; 139(36):12550-12558.
PMID: 28823165
PMC: 5677763.
DOI: 10.1021/jacs.7b05937.
